| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 氨基酸类原料药(元) | 276,082,879.94 | 142,561,890.39 | 295,663,386.85 | 156,693,845.00 |
| 甾体激素类(元) | 1,846,610,867.26 | 992,279,766.72 | 1,731,606,124.55 | 1,061,437,479.76 |
| 其中:制剂(元) | 753,444,289.10 | - | - | - |
| 其他(元) | 767,543,709.91 | 444,403,721.41 | 1,162,253,751.68 | 569,074,671.24 |
| 营业成本(元) | ||||
| 氨基酸类原料药(元) | 173,048,847.84 | 79,619,009.78 | 175,130,310.52 | 86,976,722.96 |
| 甾体激素类(元) | 1,044,157,029.13 | 590,898,940.39 | 1,078,938,356.19 | 683,940,854.34 |
| 其中:制剂(元) | 464,230,132.79 | - | - | - |
| 其他(元) | 486,412,879.48 | 247,693,341.32 | 474,336,033.95 | 185,520,924.36 |
| 毛利(元) | ||||
| 氨基酸类原料药(元) | 103,034,032.10 | 62,942,880.61 | 120,533,076.33 | 69,717,122.04 |
| 甾体激素类(元) | 802,453,838.13 | 401,380,826.33 | 652,667,768.36 | 377,496,625.42 |
| 其中:制剂(元) | 289,214,156.31 | - | - | - |
| 其他(元) | 281,130,830.43 | 196,710,380.09 | 687,917,717.73 | 383,553,746.88 |
| 毛利率(%) | ||||
| 氨基酸类原料药(%) | 37.32 | 44.15 | 40.77 | 44.49 |
| 甾体激素类(%) | 43.46 | 40.45 | 37.69 | 35.56 |
| 其中:制剂(%) | 38.39 | - | - | - |
| 其他(%) | 36.63 | 44.26 | 59.19 | 67.40 |
| 收入构成(%) | ||||
| 氨基酸类原料药(%) | 7.58 | 9.03 | 9.27 | 8.77 |
| 甾体激素类(%) | 50.68 | 62.83 | 54.29 | 59.39 |
| 其中:制剂(%) | 20.68 | - | - | - |
| 其他(%) | 21.07 | 28.14 | 36.44 | 31.84 |
| 毛利构成(%) | ||||
| 氨基酸类原料药(%) | 6.98 | 9.52 | 8.25 | 8.39 |
| 甾体激素类(%) | 54.37 | 60.72 | 44.67 | 45.44 |
| 其中:制剂(%) | 19.60 | - | - | - |
| 其他(%) | 19.05 | 29.76 | 47.08 | 46.17 |